Rapamycin, but Not FK-506, Increases Endothelial Tissue Factor Expression: Implications for Drug-Eluting Stent Design

Circulation - United States
doi 10.1161/circulationaha.105.569129
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Fatal Infection After Rapamycin Eluting Coronary Stent Implantation

Heart
Cardiovascular MedicineCardiology
2005English

Drug-Eluting Stent Restenosis Rates?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Kidney Transplantation Under FK 506

JAMA - Journal of the American Medical Association
Medicine
1990English

Antiplatelet Therapy After Drug-Eluting Stent Implantation

Journal of Cardiology
Cardiovascular MedicineCardiology
2015English

Development of Polymeric Coating Material for Effective Drug-Eluting Stent

Polymer (Korea)
PolymersMaterials ChemistryPlasticsChemical Engineering
2011English

Antifungal Properties of the Immunosuppressant FK-506: Identification of an FK-506-responsive Yeast Gene Distinct From FKB1.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1991English

Characteristics and Predictors of Drug-Eluting Stent Thrombosis

Circulation Journal
MedicineCardiovascular MedicineCardiology
2011English

Network Meta-Analysis of Balloon Angioplasty, Nondrug Metal Stent, Drug-Eluting Balloon, and Drug-Eluting Stent for Treatment of Infrapopliteal Artery Occlusive Disease

Diagnostic and Interventional Radiology
Nuclear MedicineRadiologyCardiovascular MedicineImagingCardiology
2016English

Direct Targeting of the mTOR (Mammalian Target of Rapamycin) Kinase Improves Endothelial Permeability in Drug-Eluting Stents

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy